Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?

Copland DA, Liu J, Chan YK, Dick AD, Clare AJ

Open source

DOI
10.1016/j.ymthe.2026.03.029
Published
2026 Jun 3
Container
Molecular therapy : the journal of the American Society of Gene Therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymthe.2026.03.029,
  title = {Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?},
  author = {Copland DA and Liu J and Chan YK and Dick AD and Clare AJ},
  year = {2026},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  doi = {10.1016/j.ymthe.2026.03.029},
  url = {https://doi.org/10.1016/j.ymthe.2026.03.029}
}

RIS

TY  - JOUR
TI  - Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?
AU  - Copland DA
AU  - Liu J
AU  - Chan YK
AU  - Dick AD
AU  - Clare AJ
PY  - 2026
JO  - Molecular therapy : the journal of the American Society of Gene Therapy
DO  - 10.1016/j.ymthe.2026.03.029
UR  - https://doi.org/10.1016/j.ymthe.2026.03.029
ER  - 

APA

DA, C., J, L., YK, C., AD, D., & AJ, C. (2026). Can NRF2 provide a gene-agnostic approach to treating age-related macular degeneration?. Molecular therapy : the journal of the American Society of Gene Therapy. https://doi.org/10.1016/j.ymthe.2026.03.029

Source records